Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterserve Regulatory News (IRV)

  • There is currently no data for IRV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

20 Jul 2006 17:52

Interserve PLC20 July 2006 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART INTO THE UNITEDSTATES, AUSTRALIA, CANADA OR JAPAN FOR IMMEDIATE RELEASE INTERSERVE PLC AND MACLELLAN GROUP PLC - SCHEME OF ARRANGEMENT EFFECTIVE The Board of Interserve is pleased to announce that the Scheme to implement itsrecommended acquisition of MacLellan has now become effective in accordance withits terms and the acquisition of MacLellan by Interserve has completed. Accordingly, dealings in MacLellan Shares on the London Stock Exchange will becancelled and the MacLellan Shares delisted at commencement of business on 21July 2006. The New Interserve Shares offered to MacLellan Shareholders inconnection with the acquisition of MacLellan Shares, totalling 9,411,481 NewInterserve Shares, will be issued and admitted to trading on the London StockExchange with effect from 8.00am on 21 July 2006. The latest date for the despatch of cheques in respect of the cash considerationpayable, or settlement of cash consideration and New Interserve Shares throughCREST (as appropriate) and statements of entitlements to or share certificatesin relation to New Interserve Shares (as appropriate), is 3 August 2006. As valid elections for the Loan Note Alternative did not exceed at least £2million in nominal value of Loan Notes, no Loan Notes will be issued andMacLellan Shareholders who elected for the Loan Note Alternative will insteadreceive the cash consideration to which they were entitled in respect of suchelections. Terms defined in Interserve's announcement dated 2 May 2006 have the samemeaning in this announcement. Enquiries: Interserve plc +44 (0)11 8932 0123 Adrian Ringrose, Chief Executive, Tim Jones, Finance Director, Giles Scott, Headof Corporate Communications JPMorgan Cazenove +44 (0)20 7588 2828 Patrick Magee, Clare Strange The Maitland Consultancy +44 (0)20 379 5151 Neil Bennett (+44 (0)7900 000 777), Liz Morley (+44 (0)7798 683 108) MacLellan Group plc + 44 (0)1905 744 400 John Foley, Stephen Shipley Investec +44 (0) 207 597 5970 David Currie, Daniel Adams This announcement does not constitute an offer to sell or invitation to purchaseany securities or the solicitation of any vote for approval in any jurisdiction,nor shall there be any sale, issue or transfer of the securities referred to inthis announcement in any jurisdiction in contravention of applicable law. The release, publication or distribution of this announcement in certainjurisdictions may be restricted by law. The availability of the New InterserveShares and the Mix and Match Facility and the Loan Note Alternative under theterms of the Scheme (or, if the offer is implemented by way of a takeover offer,of that offer), if made, to persons not resident in the United Kingdom may beaffected by the laws of the relevant jurisdictions in which they are located.Persons who are not resident in the United Kingdom or who are subject to otherjurisdictions should inform themselves of, and observe, any applicablerequirements. Further details in relation to Overseas Persons who are MacLellanShareholders will be contained in the Scheme Document. This announcement and the Acquisition are not an offer of securities for sale inthe US or in any jurisdiction in which such an offer is unlawful. The NewInterserve Shares have not been, and will not be, registered under the USSecurities Act of 1933 (the 'Securities Act') or under the securities laws ofany state, district or other jurisdiction of the US, Australia, Canada or Japanand no regulatory clearance in respect of the New Interserve Shares has been, orwill be, applied for in any jurisdiction other than the UK. It is expected thatthe New Interserve Shares will be issued in reliance upon the exemption from theregistration requirements of the Securities Act provided by Section 3(a) (10)thereof. Under applicable US securities laws, MacLellan Shareholders who are orwill be deemed to be 'affiliates' of MacLellan or Interserve prior to, or ofInterserve after, the Effective Date will be subject to certain transferrestrictions relating to the New Interserve Shares received in connection withthe Acquisition. Relevant clearances have not been, and will not be, obtainedfrom the securities commission or similar authority of any province or territoryof Canada and no prospectus, information memorandum or other documents relatingto the New Interserve Shares has been or will be filed or registration madeunder any securities laws of any province or territory of Canada nor has anyprospectus, information memorandum or other documents relating to the NewInterserve Shares been, or will be, lodged with, or registered by, theAustralian Securities Investments Commission or the Japanese Ministry of Financeand the New Interserve Shares have not been, and nor will they be, registeredunder or offered in compliance with applicable securities laws of any state,province, territory or jurisdiction of Canada, Australia or Japan. Accordingly,unless an exemption under relevant securities laws is applicable, the NewInterserve Shares may not be offered, sold, resold or delivered, directly orindirectly, in or into Canada, Australia, Japan or any other jurisdiction whereto do so would constitute a violation of the relevant laws of, or requireregistration thereof in, such jurisdiction or to, or for the account or benefitof, a person located in Canada, Australia or Japan. JPMorgan Cazenove, which is authorised and regulated in the United Kingdom bythe Financial Services Authority, is acting exclusively for Interserve and noone else in connection with the Acquisition and will not be responsible toanyone other than Interserve for providing the protections afforded to clientsof JPMorgan Cazenove or for providing advice in relation to the Acquisition, thecontents of this announcement, or any matter referred to herein. Investec, which is authorised and regulated in the United Kingdom by theFinancial Services Authority, is acting exclusively for MacLellan and no oneelse in connection with the Acquisition and will not be responsible to anyoneother than MacLellan for providing the protections afforded to clients ofInvestec or for providing advice in relation to the Acquisition, the contents ofthis Announcement or any matter referred to herein. ENDS This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
15th Mar 20196:27 pmRNSInterserve
15th Mar 20195:56 pmRNSSuccessful completion of sale of the Group
15th Mar 20192:47 pmRNSHolding(s) in Company
15th Mar 20192:01 pmRNSParent Company Administration
15th Mar 201912:33 pmRNSResult of General Meeting
14th Mar 201911:41 amRNSTotal Voting Rights and Warrant Update
14th Mar 20199:18 amRNSDirector/PDMR Shareholding
12th Mar 20198:30 amRNSBlock Listing Application
11th Mar 20195:27 pmRNSResponse to media reports re Deleveraging Plan
5th Mar 201912:56 pmRNSResponse to proposal Coltrane Asset Management L.P
4th Mar 20196:03 pmRNSUpdate on Coltrane Asset Management L.P Proposal
28th Feb 20199:58 amRNSPublication of a Prospectus
27th Feb 20199:05 amRNSDeleveraging Plan details and launch
27th Feb 20198:58 amRNSFull Year Results 2018
26th Feb 20194:17 pmRNSNotice of Requisition General Meeting
22nd Feb 20193:54 pmRNSHolding(s) in Company
22nd Feb 20193:50 pmRNSUpdate on Deleveraging Plan
20th Feb 20199:56 amRNSHolding(s) in Company
19th Feb 201910:13 amRNSHolding(s) in Company
13th Feb 20194:25 pmRNSDirector/PDMR Shareholding
12th Feb 20197:00 amRNSDirectorate Change
6th Feb 20197:10 amRNSStatement re Shareholder Requisition
6th Feb 20197:00 amRNSStatement re Deleveraging Plan
24th Jan 201912:07 pmRNSSecond Price Monitoring Extn
24th Jan 201912:02 pmRNSPrice Monitoring Extension
16th Jan 20191:14 pmRNSDirector/PDMR Shareholding
14th Jan 20194:41 pmRNSSecond Price Monitoring Extn
14th Jan 20194:36 pmRNSPrice Monitoring Extension
2nd Jan 201912:30 pmRNSHolding(s) in Company
2nd Jan 20197:00 amRNSBlock listing Interim Review
28th Dec 20184:20 pmRNSHolding(s) in Company
21st Dec 20187:00 amRNSProgress on Deleveraging Plan
17th Dec 20182:52 pmRNSDirector/PDMR Shareholding
10th Dec 20189:30 amRNSInterserve Awarded £25m Contract.
10th Dec 20187:00 amRNSDELEVERAGING PLAN
29th Nov 20182:30 pmRNSHolding(s) in Company
28th Nov 201810:50 amRNSHolding(s) in Company
27th Nov 20183:59 pmRNSHolding(s) in Company
23rd Nov 20182:07 pmRNSHolding(s) in Company
23rd Nov 20187:00 amRNS3rd Quarter Update
16th Nov 20184:12 pmRNSHolding(s) in Company
16th Nov 20184:09 pmRNSHolding(s) in Company
13th Nov 20182:50 pmRNSStatement following recent press coverage
13th Nov 201811:00 amRNSDirector/PDMR Shareholding
23rd Oct 201811:03 amRNSHolding(s) in Company
22nd Oct 20184:27 pmRNSHolding(s) in Company
17th Oct 20189:04 amRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSSALE OF ACCESS AND HARD SERVICES BUSINESS
1st Oct 20189:27 amRNSHolding(s) in Company
14th Sep 20189:58 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.